This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: City of Hope, Imugene Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 2 Years Active: 2026
Title: Anthony K. Park: Inventor in Oncolytic Virus Research
Introduction
Anthony K. Park is an inventor associated with Pomona, California. His patent work concerns oncolytic viruses and potential approaches to treating solid tumors.
Latest Patents
Park is named on one patent, titled “Methods Comprising Oncolytic Viruses Expressing CD19T and Bispecific T Cell Engagers.” The patent describes oncolytic viruses expressing truncated human CD19 (CD19t) and methods for treating solid tumors by administering such a virus, optionally alongside a CD19-targeted T-cell engager. Park’s listed portfolio includes 1 patent.
Career Highlights
Park’s professional affiliations include City of Hope and Imugene Ltd. His patent reflects work at the intersection of oncolytic virus research and immune-cell engagement.
Collaborations
Park’s listed coworkers include Saul J. Priceman and Yuman Fong. Their shared research context includes the development of approaches involving oncolytic viruses and cancer treatment.
Conclusion
Anthony K. Park’s patent focuses on combining CD19-expressing oncolytic viruses with potential T-cell-engaging strategies for treating solid tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile